Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines for Cerebral Ischemia‐Reperfusion Injury Treatment
Advanced Healthcare Materials · 2026-01 · 15 (4)
DOI: 10.1002/adhm.202502936 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.09.2025. Verfasst von Yihong Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, 200093, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Nanomedicine, Biomimetic Materials, Cell Membrane. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Discipline Construction of Pudong New Area Health Commission, Shanghai Pudong New District Health Committee Health Industry Special Project.
Abstract (Originalsprache)
Cerebral ischemia–reperfusion injury (CIRI) involves complex pathological processes, including multifaceted inflammatory responses and the extensive recruitment of immune cells, ultimately leading to neuronal damage and functional impairment. Although nanomedicine‐based delivery platforms have demonstrated considerable potential in the treatment of CIRI, their therapeutic efficacy is frequently hindered by rapid systemic clearance and non‐specific biodistribution. In recent years, Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines (CMBNs) have emerged as a promising strategy to address these challenges, owing to their inherent biocompatibility and targeting capabilities. By mimicking the structure and function of natural cell membranes, these nanosystems enable immune evasion, extend systemic circulation, and enhance targeted delivery to sites of inflammation. This review systematically summarizes the preparation methods of CMBNs, elucidates the functional properties imparted by membranes derived from various cellular sources (including erythrocytes, platelets, and immune cells), and discusses the targeting enhancements achieved via surface modifications. Furthermore, this review addresses the challenges faced in the clinical translation of these bio‐nanosystems, including large‐scale production, quality control, potential toxicity and biosafety concerns. By thoroughly examining the application of cell membrane‐based bionanosystems in CIRI therapy, this review aims to offer both theoretical and practical guidance for the future development of efficient and safe bionanotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, 200093, China.
- Department of Radiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, China.
- Department of Hematology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, China.
- Department of Radiology, Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, P. R. China.
- School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
- Discipline Construction of Pudong New Area Health Commission
- Shanghai Pudong New District Health Committee Health Industry Special Project
- The Investigator-initiated Trial Program of Shanghai Pudong New Area Health Commission
Zitieren
APA
Su, Y., Huang, B., Liu, D., Yu, L., & Chen, Y. (2026). Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines for Cerebral Ischemia‐Reperfusion Injury Treatment. Advanced Healthcare Materials, 15(4). https://doi.org/10.1002/adhm.202502936
Vancouver
Su Y, Huang B, Liu D, Yu L, Chen Y. Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines for Cerebral Ischemia‐Reperfusion Injury Treatment. Advanced Healthcare Materials. 2026;15(4). doi:10.1002/adhm.202502936
BibTeX
@article{Su2026,
author = {Su, Yihong and Huang, Bingcang and Liu, Dingsheng and Yu, Luodan and Chen, Yu},
title = {Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines for Cerebral Ischemia‐Reperfusion Injury Treatment},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/adhm.202502936}
}
EUVIMED